Advocacy & Public Policy

Because Patients Can’t WaitSM, BioNJ advocates for the life sciences industry in New Jersey and in Washington, addressing issues and programs on both the State and Federal levels. As the New Jersey affiliate of the Biotech Innovation Organization (BIO), we work collaboratively with BIO and other industry organizations to advance issues that bring faster treatments and cures to Patients and support the life sciences in New Jersey.

Advocacy and public policy are integral to our mission at BioNJ. Our program is based on support for these principles:

  • Advocating for policy decisions that will nurture and grow New Jersey’s life sciences ecosystem, a leading economic driver and job creator for our State
  • Increasing information and engagement for our BioNJ Members
  • Creating enhanced collaborations that lead to more innovation and scientific research and development conducted in New Jersey

 

2016 BioNJ government affairs activity includes:

  • Partnering with Rare New Jersey and the National Organization for Rare Disorders (NORD) at Rare Disease Day events in New Jersey in January
  • Leading a delegation of senior executives at BIO’s Legislative Fly-In in April in meetings with New Jersey’s Senators and Members of the Congressional Delegation and staff in Washington
  • Hosting briefings and receptions for Congressional staffers in Washington

Participating as a Board Member in OpportunityNJ, whose mission is to increase awareness of the impact that policies and legislative action will have on the State’s economy and job growth for New Jersey citizens